• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nexalin Technology, Inc. - Common Stock (NQ: NXL )

    2.880 +0.150 (+5.49%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 301,484
    Open 2.840
    Bid (Size) 2.800 (1)
    Ask (Size) 2.900 (9)
    Prev. Close 2.730
    Today's Range 2.650 - 2.880
    52wk Range 0.2528 - 4.490
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic
    AI Components for Electronic Data Capture and Patient Monitoring to be Integrated into Phase 2 
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market
    Report Highlights Nexalin’s Unique Non-Invasive Solution Addressing Deep Brain Dysfunction, Positioned to Revolutionize Mental Health Treatment 
    From Nexalin Technology, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +623.07%
    +623.07%
    1 Month
    -25.19%
    -25.19%
    3 Month
    +329.59%
    +329.59%
    6 Month
    -2.70%
    -2.70%
    1 Year
    +638.46%
    +638.46%

    More News

    Read More
    (NXL) - Analyzing Nexalin Technology's Short Interest
    Via Benzinga
    Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Nexalin Technology CEO Provides Letter to Shareholders
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients
    Via Benzinga
    NASDAQ Stocks Under $1 to Watch in October 2024: LGCB, KAVL, NXL, NXU, FAMI
    Via AB Newswire
    Topics Economy Electric Vehicles
    Exposures Electric Vehicles Supply Chain
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study
    Via Benzinga
    Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.